Intrinsic Genetic Characteristics Determine Tumor-modifying Capacity of Fibroblasts: Matrix Metalloproteinase-3 5A/5A Genotype Enhances Breast Cancer Cell Invasion

Overview

Journal Breast Cancer Res

Specialty Oncology

Date 2007 Oct 10

PMID 17922906

Citations 21

Authors

Deborah L Holliday

Simon Hughes

Jacqueline A Shaw

Rosemary A Walker

J Louise Jones

Affiliations

Soon will be listed here.

Abstract

Background: Stromal fibroblasts can contribute to tumor invasion through the release of matrix metalloproteinases (MMPs). Population studies have suggested that single nucleotide polymorphisms (SNPs) in MMP genes influence levels of expression and may be associated with breast cancer risk and with disease progression. This study directly examined the impact of MMP SNP genotype on the ability of host fibroblasts to promote tumor cell invasion.

Methods: Primary breast fibroblasts were isolated from patients with (n = 13) or without (n = 19) breast cancer, and their ability to promote breast cancer cell invasion was measured in in vitro invasion assays. Fibroblast invasion-promoting capacity (IPC) was analyzed in relation to donor type (tumor or non-tumor patient), MMP-1, MMP-3, and MMP-9 SNP genotype and MMP activity using independent samples t test and analysis of variance. All statistical tests were two-sided.

Results: Tumor-derived fibroblasts promoted higher levels of invasion than normal fibroblasts (p = 0.041). When IPC was related to genotype, higher levels of IPC were generated by tumor fibroblasts with the high-expressing MMP-3 5A/5A genotype compared with the 5A/6A and 6A/6A genotypes (p = 0.05 and 0.07, respectively), and this was associated with enhanced MMP-3 release. The functional importance of MMP-3 was demonstrated by enhanced invasion in the presence of recombinant MMP-3, whereas reduction occurred in the presence of a specific MMP-3 inhibitor. An inverse relationship was demonstrated between fibroblast IPC and the high-expressing MMP-1 genotype (p = 0.031), but no relationship was seen with MMP-9 SNP status. In contrast, normal fibroblasts showed no variation in IPC in relation to MMP genotype, with MMP-3 5A/5A fibroblasts exhibiting significantly lower levels of IPC than their tumor-derived counterparts (p = 0.04).

Conclusion: This study has shown that tumor-derived fibroblasts exhibit higher levels of IPC than normal fibroblasts and that the MMP-3 5A/5A genotype contributes to this through enhanced MMP-3 release. Despite a high-expressing genotype, normal fibroblasts do not exhibit higher IPC or enhanced MMP release. This suggests that more complex changes occur in tumor-derived fibroblasts, enabling full expression of the MMP SNP genotype and these possibly are epigenetic in nature. The results do suggest that, in women with breast cancer, a high-expressing MMP-3 genotype may promote tumor progression more effectively.

Citing Articles

Significant Association of Matrix Metalloproteinase-9 Polymorphisms With Triple Negative Breast Cancer Risk.

Hung C, Wang Y, Shih H, Liu C, He J, Chen J Cancer Genomics Proteomics. 2025; 22(2):258-270.

PMID: 39993804 PMC: 11880922. DOI: 10.21873/cgp.20500.

Impact of rs243865 and rs3025058 Polymorphisms on Clinical Findings in Alzheimer's Disease Patients.

Durmanova V, Javor J, Parnicka Z, Minarik G, Ocenasova A, Vaseckova B Mediators Inflamm. 2021; 2021:5573642.

PMID: 33986628 PMC: 8079184. DOI: 10.1155/2021/5573642.

Influence of Fibroblasts on Mammary Gland Development, Breast Cancer Microenvironment Remodeling, and Cancer Cell Dissemination.

Avagliano A, Fiume G, Ruocco M, Martucci N, Vecchio E, Insabato L Cancers (Basel). 2020; 12(6).

PMID: 32604738 PMC: 7352995. DOI: 10.3390/cancers12061697.

Matrix Metallopeptidase 3 Polymorphisms: Emerging genetic Markers in Human Breast Cancer Metastasis.

Ahmad Suhaimi S, Chan S, Rosli R J Breast Cancer. 2020; 23(1):1-9.

PMID: 32140265 PMC: 7043940. DOI: 10.4048/jbc.2020.23.e17.

Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma.

Mehner C, Miller E, Nassar A, Bamlet W, Radisky E, Radisky D Genes Cancer. 2016; 6(11-12):480-9.

PMID: 26807201 PMC: 4701227. DOI: 10.18632/genesandcancer.90.

References

Roskelley C, Bissell M . The dominance of the microenvironment in breast and ovarian cancer. Semin Cancer Biol. 2002; 12(2):97-104. PMC: 3771861. DOI: 10.1006/scbi.2001.0417. View

Sternlicht M, Werb Z . How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001; 17:463-516. PMC: 2792593. DOI: 10.1146/annurev.cellbio.17.1.463. View

Howe J, Roth S, Ringold J, Summers R, Jarvinen H, Sistonen P . Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998; 280(5366):1086-8. DOI: 10.1126/science.280.5366.1086. View

Bhowmick N, Neilson E, Moses H . Stromal fibroblasts in cancer initiation and progression. Nature. 2004; 432(7015):332-7. PMC: 3050735. DOI: 10.1038/nature03096. View

Bhowmick N, Chytil A, Plieth D, Gorska A, Dumont N, Shappell S . TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 2004; 303(5659):848-51. DOI: 10.1126/science.1090922. View

Duffy M, Maguire T, Hill A, McDermott E, OHiggins N . Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res. 2001; 2(4):252-7. PMC: 138784. DOI: 10.1186/bcr65. View

Fukino K, Shen L, Matsumoto S, Morrison C, Mutter G, Eng C . Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res. 2004; 64(20):7231-6. DOI: 10.1158/0008-5472.CAN-04-2866. View

Sipley J, Nagase H, French D, Quigley J . Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem. 1999; 274(19):13066-76. DOI: 10.1074/jbc.274.19.13066. View

Rutter J, Mitchell T, Buttice G, Meyers J, Gusella J, Ozelius L . A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998; 58(23):5321-5. View

10.

Howlett A, Bissell M . The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol. 1993; 2(2):79-89. View

11.

Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R . Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005; 121(3):335-48. DOI: 10.1016/j.cell.2005.02.034. View

12.

Hu M, Yao J, Cai L, Bachman K, van den Brule F, Velculescu V . Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet. 2005; 37(8):899-905. DOI: 10.1038/ng1596. View

13.

Blavier L, Lazaryev A, Dorey F, Shackleford G, DeClerck Y . Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis. Cancer Res. 2006; 66(5):2691-9. DOI: 10.1158/0008-5472.CAN-05-2919. View

14.

Sternlicht M, Bissell M, Werb Z . The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene. 2000; 19(8):1102-13. PMC: 2933206. DOI: 10.1038/sj.onc.1203347. View

15.

Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H . Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004; 6(1):17-32. DOI: 10.1016/j.ccr.2004.06.010. View

16.

Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y . Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer. 2002; 102(5):526-9. DOI: 10.1002/ijc.10750. View

17.

Kalluri R, Zeisberg M . Fibroblasts in cancer. Nat Rev Cancer. 2006; 6(5):392-401. DOI: 10.1038/nrc1877. View

18.

Ghilardi G, Biondi M, Caputo M, Leviti S, DeMonti M, Guagnellini E . A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res. 2002; 8(12):3820-3. View

19.

Wyatt C, Coon C, Gibson J, Brinckerhoff C . Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res. 2002; 62(24):7200-2. View

20.

Jones J, Shaw J, Pringle J, Walker R . Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells. J Pathol. 2003; 201(4):562-72. DOI: 10.1002/path.1483. View